Unknown

Dataset Information

Therapeutics for COVID-19 and post COVID-19 complications: An update.


ABSTRACT: Since its inception in late December 2020 in China, novel coronavirus has affected the global socio-economic aspect. Currently, the world is seeking safe and effective treatment measures against COVID-19 to eradicate it. Many established drug molecules are tested against SARS-CoV-2 as a part of drug repurposing where some are proved effective for symptomatic relief while some are ineffective. Drug repurposing is a practical strategy for rapidly developing antiviral agents. Many drugs are presently being repurposed utilizing basic understanding of disease pathogenesis and drug pharmacodynamics, as well as computational methods. In the present situation, drug repurposing could be viewed as a new treatment option for COVID-19. Several new drug molecules and biologics are engineered against SA

SUBMITTER: Basu D 

PROVIDER: S-EPMC8813675 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature